Developing novel nuclear cardiology approaches requires evaluating their diagnostic ability. Statistical measures such as sensitivity, specificity, receiver operating characteristic (ROC) curve, and area under the curve (AUC) are useful to evaluate the diagnostic value of novel imaging parameters. This paper reviews key statistical methods used in the evaluation of diagnostic tests and highlights their use in clinical research settings. For all diagnostic tests within a symptomatic population, the goal is to provide an accurate diagnosis (without false diagnoses) at a justifiable cost. To assess the performance of a test, it is usually compared to a "gold" standard (e.g. histology, blood test, better imaging modality). The gold standard (GS) is not always perfect, but must be accepted as the best available measure based on standards and validation of the test (i.e. the best results in many studies). The GS itself may not be used routinely for a variety of reasons, such as cost, time constraints, invasiveness, or expertise required. The GS is a best available surrogate for the true presence or absence of disease. The presence or absence of disease or condition references throughout this article relate to whether the GS showed presence or absence of disease or condition.
. This paper reviews these key statistical approaches and highlights their use in the article by Tanaka et al.
Diagnostic testing with binary imaging parameters
A variety of cardiac imaging techniques may be used to aid in the diagnosis of suspected cardiac disease in high-risk patients. To be effective, parameters derived from imaging techniques must be able to distinguish between patients with cardiac disease or conditions and those without. For all diagnostic tests within a symptomatic population, the goal is to provide an accurate diagnosis (without false diagnoses) at a justifiable cost. To assess the performance of a test, it is usually compared to a "gold" standard (e.g. histology, blood test, better imaging modality). The gold standard (GS) is not always perfect, but must be accepted as the best available measure based on standards and validation of the test (i.e. the best results in many studies). The GS itself may not be used routinely for a variety of reasons, such as cost, time constraints, invasiveness, or expertise required. The GS is a best available surrogate for the true presence or absence of disease. The presence or absence of disease or condition references throughout this article relate to whether the GS showed presence or absence of disease or condition.
In order to assess the ability of an imaging test, key results need to be considered. These results are best displayed in the following are properties of the test, regardless of the population to which it is applied. In contrast, PPV, NPV and ACC depend on both the test and the prevalence of the disease. Therefore, the design of the study that provides these measures (and in particular the study prevalence of disease) must be considered as well as the prevalence in the population that will be tested in the future. A test with excellent sensitivity could have a very poor PPV because, if the condition is rare, most of the positives will be false positives. Conversely a test with excellent specificity could have a poor NPV, because if the condition is common, most of the negatives will be false negatives. For further clarification, suppose the study is done by sampling 100 cases and 100 controls, the prevalence in the study data will be 50%, but in practice the disease may be extremely rare and the PPV and NPV estimated from the study data will not be useful. On the other hand, if the study design was cross-sectional or prospective (randomly sampled from the population) then there is at least a better chance that prevalence in the study will reflect the population prevalence, and in this case PPV and NPV from the study can be It is important to keep in mind that with rare diseases SpIn is not appropriate since ruling in disease based on a patient's positive test is not reasonable (PPV is too low). It is also important to remember false positives and false negatives may not be equally undesirable; in a given diagnostic situation one may have higher costs, either financial or ethical, than the other. In situations where initial tests are used to identify patients that need additional more invasive tests, more false positives may be acceptable in the first round of testing
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Ann Nucl Cardiol 2016；2（1） ：174-177 -175 - (Fig. 1) . The area under the ROC curve (AUC --also known as the c statistic) provides a measure of the overall discrimination ability of the test, e.g. how well the test distinguishes between those who have the disease versus those who do not. The AUC ranges between 0 and 1.0 (or 0 and 100%) and can be assessed as follows: ・c=0.5 suggests no discrimination (i.e. we might as well flip a coin) ・0.7≤c<0.8 acceptable discrimination ・0.8≤c<0.9 excellent discrimination ・c≥0.9 outstanding discrimination.
The more the curve follows the y axis and then the x axis the better the discrimination. The diagonal line shows no discrimination (c=0.5; Fig. 1 ). Another useful interpretation of AUC is that it provides the probability that if you take a random person with the disease and a random person without the disease, the person with the disease will score "higher" on the test (assuming a high score indicates higher risk of disease) than the non-diseased person.
In addition, a measurement value that maximizes sensitivity and specificity can be derived from the curve. It is impossible to maximize both sensitivity and specificity simultaneously.
One has to be traded for the other. Therefore the most common method is to choose the cutpoint that maximizes the sum of Se and Sp. This provides a cutpoint to convert the continuous imaging parameters into a binary measure that can be used in the diagnostic statistics calculations. 
A clinical research application
The study by Tanaka et al. considered three accepted imaging measures for detecting multivessel CAD: summed stress score (SSS), summed rest score (SRS) and summed difference score (SDS). In addition, they analyzed two novel measures: LV dyssynchony applying phase analysis to measure phase standard deviation (Phase SD) and histogram bandwidth (HB). Since all are continuous measures, ROC analysis showed that SDS had the highest AUC (0.81) (Fig.1) .
The optimal cutpoints were determined using the ROC curves.
These cutpoints maximize the sum of sensitivity plus The ROC curve and its 95% confidence intervals and the AUC at 0.5 are represented on the figure. The cutpoint for multivessel CAD was defined as a summed difference score of > 5. With this dichotomizing of SDS the sensitivity is 74% and specificity is 78% (the black dot on the ROC curve maximizes the sum of the sensitivity and specificity). specificity. Tanaka et al. concluded that SDS alone provided the highest accuracy of 76%, with sensitivity of 74% and specificity of 78%. By adding the consideration of Phase SD and HB with SDS to detect multivessel CAD, the sensitivity increased to 82% while specificity was 76%. In multivariate analysis, these three imaging parameters were significantly associated with multivessel CAD (p<0.05). Tanaka 
Conclusion
It is essential that practitioners within the field of nuclear cardiology continue to advance diagnostic imaging tests and make full use of statistical tests such as those reviewed in this article. The 7 key statistics described should be calculated in order to understand the potential utility of new diagnostic tests. LR + and LR-are important statistical measures that should be more frequently used than they are at present.
Increasing incorporation of these statistical techniques into the field of nuclear cardiology will allow for continued improvement in the accuracy and utility of its diagnostic testing.
